αααααβααΎαG1LP34 β’ BVMF
add
Galapagos Nv Bdr
9.04Β R$
22 ααααΌ, 10:10:35 PM ααααβααα -3 · BRL · BVMF · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
9.04Β R$
α
αααααααααααα
9.04Β R$ - 9.04Β R$
α
ααααααα½αααααΆαα
α»αααααα
6.48Β R$ - 10.00Β R$
ααΎαβαα»αβααΈααααΆα
2.14Β αααΈααΆα USD
ααα ααα½αααΌαααααα
17.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (EUR) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 71.16Β ααΆα | 18.90% |
α
αααΆαααααα·ααααα·ααΆα | 28.10Β ααΆα | 33.26% |
α
αααΌααα»ααα | -202.11Β ααΆα | -300.78% |
ααααΆααα
αααααα»ααα | -284.02 | -237.08% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | -0.18 | 75.95% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -33.23Β ααΆα | 31.45% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 7.90% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (EUR) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 3.05Β αααΈααΆα | -8.65% |
ααααααααα»α | 3.51Β αααΈααΆα | -15.83% |
ααΆαααα½ααα»αααααΌαααα»α | 1.06Β αααΈααΆα | -18.68% |
ααΌαβααααα»α | 2.45Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 65.89Β ααΆα | β |
ααααααααααΉαααααα
| 0.24 | β |
ααα
ααααααΎαααααα | -2.84% | β |
ααα
ααααααΎααΎααα»α | -4.08% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (EUR) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | -202.11Β ααΆα | -300.78% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | -62.61Β ααΆα | 12.79% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 56.74Β ααΆα | 0.32% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -1.26Β ααΆα | -15.53% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -7.21Β ααΆα | 57.09% |
ααα αΌαααΆα
αααααΆααααααα | -62.98Β ααΆα | 5.41% |
α’αααΈ
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
ααΆααααααΎαα‘αΎα
1999
αααααβαααααΆα
αα»ααααα·α
558
